Omeprazole lansoprazole pantoprazole. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy3

Gastric Acid Gastric Mucosa Stomach

Organisms1

Helicobacter pylori

Diseases16

Esophagitis, Peptic Gastroesophageal Reflux Heartburn Esophagitis Helicobacter Infections Peptic Ulcer Hemorrhage Peptic Ulcer Stomach Ulcer Zollinger-Ellison Syndrome Duodenal Ulcer Dyspepsia Stomach Diseases Recurrence Colitis, Collagenous Eructation Gastrointestinal Diseases

Chemicals and Drugs46

Lansoprazole Omeprazole 2-Pyridinylmethylsulfinylbenzimidazoles Sulfoxides Anti-Ulcer Agents Proton Pump Inhibitors Benzimidazoles Esomeprazole Dexlansoprazole Rabeprazole Ranitidine Clarithromycin Amoxicillin Famotidine Metronidazole Nizatidine Histamine H2 Antagonists Antacids Aryl Hydrocarbon Hydroxylases Tablets, Enteric-Coated Proton Pumps Enzyme Inhibitors Silicic Acid Suspensions Mixed Function Oxygenases Penicillins Tablets Gefarnate Tinidazole Magnesium Hydroxide Gastrins Anti-Bacterial Agents Furazolidone H(+)-K(+)-Exchanging ATPase Aluminum Hydroxide Bismuth Cimetidine Ticlopidine Antitrichomonal Agents Cytochrome P-450 Enzyme System Urea Pentagastrin Fluvoxamine Capsules Organometallic Compounds Anti-Inflammatory Agents, Non-Steroidal

Analytical, Diagnostic and Therapeutic Techniques and Equipment19

Gastric Acidity Determination Cross-Over Studies Double-Blind Method Drug Therapy, Combination Area Under Curve Administration, Oral Breath Tests Treatment Outcome Endoscopy Drug Administration Schedule Single-Blind Method Hemostasis, Endoscopic Infusions, Intravenous Drug Incompatibility Esophagoscopy Prospective Studies Endoscopy, Gastrointestinal Metabolic Clearance Rate Intubation, Gastrointestinal

Phenomena and Processes9

Drug Interactions Hydrogen-Ion Concentration Area Under Curve Dose-Response Relationship, Drug Therapeutic Equivalency Metabolic Clearance Rate Half-Life Metabolic Detoxication, Phase I Time Factors

Information Science1

Formularies, Hospital

Health Care6

Cross-Over Studies Double-Blind Method Area Under Curve Treatment Outcome Single-Blind Method Prospective Studies

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Information Science Health Care

Lansoprazole Omeprazole 2-Pyridinylmethylsulfinylbenzimidazoles Sulfoxides Anti-Ulcer Agents Proton Pump Inhibitors Benzimidazoles Gastric Acidity Determination Gastric Acid Esomeprazole Dexlansoprazole Rabeprazole Esophagitis, Peptic Gastroesophageal Reflux Ranitidine Clarithromycin Heartburn Amoxicillin Famotidine Cross-Over Studies Esophagitis Helicobacter pylori Helicobacter Infections Metronidazole Nizatidine Histamine H2 Antagonists Antacids Aryl Hydrocarbon Hydroxylases Peptic Ulcer Hemorrhage Drug Interactions Double-Blind Method Tablets, Enteric-Coated Drug Therapy, Combination Proton Pumps Peptic Ulcer Hydrogen-Ion Concentration Stomach Ulcer Enzyme Inhibitors Area Under Curve Zollinger-Ellison Syndrome Administration, Oral Silicic Acid Suspensions Breath Tests Duodenal Ulcer Gastric Mucosa Mixed Function Oxygenases Formularies, Hospital Treatment Outcome Penicillins Tablets Gefarnate Endoscopy Dyspepsia Tinidazole Magnesium Hydroxide Gastrins Anti-Bacterial Agents Drug Administration Schedule Furazolidone Stomach Diseases Single-Blind Method Recurrence Hemostasis, Endoscopic Stomach Infusions, Intravenous Dose-Response Relationship, Drug H(+)-K(+)-Exchanging ATPase Drug Incompatibility Aluminum Hydroxide Esophagoscopy Bismuth Cimetidine Prospective Studies Ticlopidine Antitrichomonal Agents Colitis, Collagenous Eructation Cytochrome P-450 Enzyme System Gastrointestinal Diseases Endoscopy, Gastrointestinal Therapeutic Equivalency Urea Pentagastrin Metabolic Clearance Rate Fluvoxamine Half-Life Capsules Organometallic Compounds Intubation, Gastrointestinal Metabolic Detoxication, Phase I Time Factors Anti-Inflammatory Agents, Non-Steroidal

No FAQ available that match "omeprazole lansoprazole pantoprazole"